Jan 06, 2026
1:30
For every 30 shares held, investors received 1. The price per share adjusted from $0.18 to $5.27.
The split itself did not change the total investment value.
Co-Diagnostics, Inc. (LSE:0A50) operates in the Biotechnology industry.
Co-Diagnostics, Inc. company overviewCo-Diagnostics, Inc.'s most recent stock split was on January 6, 2026. It was a 1-for-30 reverse split, so shareholders received 1 share for every 30 they held.
Co-Diagnostics, Inc. has split its stock once. This history records one reverse split, on January 6, 2026.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Co-Diagnostics, Inc.'s 1-for-30 reverse split on January 6, 2026, every 30 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
Co-Diagnostics, Inc. has not announced a new split in our records. Its most recent split was on January 6, 2026, less than a year ago. Companies announce splits in advance, and any new LSE:0A50 split will appear on this page.